Article Information
PMID
Published By
Print ISSN
0258-851X
Online ISSN
1791-7549
History
- Received March 19, 2018
- Revision received March 30, 2018
- Accepted April 2, 2018
- Published online June 23, 2018.
Copyright & License
Copyright © 2018 The Author(s). Published by the International Institute of Anticancer Research.
Author Information
- 1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
- 2Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
- Correspondence to: Professor Dirk Rades, MD, Department of Radiation Oncology, University of Lübeck, Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany. Tel: +49 45150045401, Fax: +49 45150045404, e-mail: rades.dirk{at}gmx.net
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Radiotherapy of Grade III Gliomas: Identification of Clinical Prognostic Factors for Local Tumor Control and Survival
- Occurrence of Seizures Prior to Single-fraction Radiosurgery or Multi-fraction Stereotactic Radiotherapy in Patients With Very Few Brain Metastases
- A Simple Implement for Assessing the Survival of Elderly Patients With Melanoma Irradiated for Cerebral Metastases
- The Results of Whole-brain Radiotherapy for Elderly Patients With Brain Metastases from Urinary Bladder Cancer
- An Instrument to Guide Physicians when Estimating the Survival of Elderly Patients With Brain Metastasis from Gynecological Cancer
- Performance Status Is Associated With Survival in Elderly Patients Irradiated for Cerebral Metastases from Prostate Cancer
- A Scoring Tool to Estimate the Survival of Elderly Patients With Brain Metastases from Esophageal Cancer Receiving Whole-brain Irradiation
- Confirmatory Analysis of QUARTZ Study Results: Survival Prolongation After Whole-brain Radiotherapy
- Prognostic Role of Pre-Treatment Symptoms for Survival of Patients Irradiated for Brain Metastases
- Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer
- Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses
- Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM
- Serum Lactate Dehydrogenase Contributes to Prognostic Assessment in Patients With Oligometastatic Cancer and Brain Involvement
- Patterns of Treatment and Outcome in Patients With 20 or More Brain Metastases